NEONCOBREAST

2024

1. A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey

   European Journal of Surgical Oncology, Vol. 50, Núm. 10

2. Corrigendum to “European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO” [Eur J Surg Oncol 50 (1) (January 2024) 107292] (European Journal of Surgical Oncology (2024) 50(1), (S0748798323009307), (10.1016/j.ejso.2023.107292))

   European Journal of Surgical Oncology

3. Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer

   Seminars in Oncology Nursing, Vol. 40, Núm. 1

4. Dendritic Cells in Cancer Immunology and Immunotherapy

   Cancers, Vol. 16, Núm. 5

5. EUSOMA quality indicators for non-metastatic breast cancer: An update

   European Journal of Cancer, Vol. 198

6. European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO

   European Journal of Surgical Oncology, Vol. 50, Núm. 1

7. Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)

   European Journal of Nuclear Medicine and Molecular Imaging, Vol. 51, Núm. 9, pp. 2706-2732

8. Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines

   European Journal of Nuclear Medicine and Molecular Imaging

9. Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, an Update From the International PSOGI Registry

   Journal of Surgical Oncology

10. Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature

    Journal of Clinical Oncology, Vol. 42, Núm. 10, pp. 1124-1134

11. Long-term results of intraoperative multicatheter breast implant (IOMBI) for accelerated partial breast irradiation (APBI) on early breast cancer patients

    Radiotherapy and Oncology, Vol. 194

12. Multidisciplinary team meeting (MDT) in cancer care: All that glitters is not gold

    European Journal of Surgical Oncology

13. Neoadjuvant Statistical Algorithm to Predict Individual Risk of Relapse in Patients with Resected Liver Metastases from Colorectal Cancer

    Biomedicines, Vol. 12, Núm. 8

14. Post- versus intra-operative implant for breast cancer interstitial brachytherapy: How to choose?

    Journal of Contemporary Brachytherapy, Vol. 16, Núm. 1, pp. 72-83

15. Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line

    Clinical and Translational Oncology

16. Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines

    Breast, Vol. 78

17. Selecting postoperative adjuvant systemic therapy for early-stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assays

    Journal of Surgical Oncology, Vol. 130, Núm. 2, pp. 166-187

18. Treatment and outcomes in breast cancer patients: A cross section study from the EUSOMA breast centre network

    European Journal of Cancer, Vol. 196

19. Two step procedures: sequels are never any good

    Gland Surgery

20. Very accelerated partial breast irradiation in 1 or 2 days: Late toxicity and early oncological outcome of the GEC-ESTRO VAPBI cohort

    Radiotherapy and Oncology, Vol. 194